Further weakness as Autolus Therapeutics (NASDAQ:AUTL) drops 21% this week, taking five-year losses to 71%

Long-term investing is recommended, but not all stocks should be held forever. Autolus Therapeutics plc (NASDAQ:AUTL) has seen a 71% drop in share price over five years and 21% in the past week.